BMY Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline and Pipeline Advances Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress SHAZ Q1 2026 Earnings Significant EPS Miss Sends Stock Higher Despite WiderThanExpected Losses CMTG Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Challenging Mortgage Market FAF Q1 2026 Earnings EPS Beat by 256 Despite Mixed Market Reaction MBOT Q1 2026 Earnings Narrowerthanexpected loss as Microbot advances surgical robotics pipeline